Investing
Cathie Wood's ARK Invest Sells Over 140,000 More Shares of Pfizer
November 11, 2021 7:35 am
A day after one ARK Invest exchange-traded fund run by ETF star Cathie Wood parted with more than $11 million worth of Pfizer Inc. (NYSE: PFE) shares, that fund was back at it on Wednesday. Specifically, it sold over 140,000 more shares, as the price of this ETF pulled back over 4% in the day’s session. However, it is up a fair amount in the past year.
It was ARK Genomic Revolution ETF (NYSEARCA: ARKG) that shed 140,713 shares of Pfizer. At Wednesday’s closing price, this would have valued this sale at roughly $6.9 million. This is only a small fraction of the total holdings. The fund is up about 7% over the past 52 weeks.
Check out all the ARK Invest sales for Wednesday:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKG | CLLS | CELLECTIS | 8,300 |
| ARKG | PFE | PFIZER | 140,713 |
| ARKG | REGN | REGENERON PHARMACEUTICALS | 11,602 |
| ARKK | U | UNITY SOFTWARE | 113,490 |
| ARKQ | U | UNITY SOFTWARE | 15,700 |
| ARKW | U | UNITY SOFTWARE | 28,889 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.
Sponsored: Find a Qualified Financial Advisor:
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
Editors' Picks
